True Wealth Design’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.7K Sell
136
-26
-16% -$13.4K 0.02% 373
2026
Q2
$87.8K Buy
162
+4
+3% +$2.25K 0.02% 293
2026
Q1
$93.7K Sell
158
-80
-34% -$39.8K 0.03% 228
2025
Q4
$116K Buy
238
+129
+118% +$60.1K 0.03% 157
2025
Q3
$45.7K Buy
109
+96
+738% +$32.3K 0.01% 341
2025
Q2
$3.74K Buy
13
+5
+63% +$1.49K ﹤0.01% 926
2025
Q1
$2.47K Sell
8
-151
-95% -$51.7K ﹤0.01% 934
2024
Q4
$56.1K Sell
159
-10
-6% -$3.68K 0.02% 145
2024
Q3
$60.6K Sell
169
-3,274
-95% -$1.11M 0.02% 109
2024
Q2
$1.1M Sell
3,443
-63
-2% -$16.7K 0.27% 29
2024
Q1
$805K Buy
3,506
+190
+6% +$42.9K 0.2% 85
2023
Q4
$729K Sell
3,316
-43
-1% -$9.9K 0.21% 96
2023
Q3
$759K Buy
3,359
+3,358
+335,800% +$773K 0.25% 73
2023
Q2
$221 Buy
+1
New +$222 ﹤0.01% 635

Other funds holding UTHR

True Wealth Design's UTHR Position: Q3 2026 in Review

True Wealth Design reduced its United Therapeutics (UTHR) stake by 16% in Q3 2026, selling an estimated $13.4K and leaving 136 shares worth $73.7K. The position accounts for 0.02% of the portfolio, ranked #373.

True Wealth Design first reported a position in UTHR in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.1M in Q2 2024. 150 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • True Wealth Design held 136 shares of United Therapeutics worth $73.7K as of Q3 2026.
  • True Wealth Design sold 26 United Therapeutics shares in Q3 2026, an estimated $13.4K.
  • United Therapeutics made up 0.02% of True Wealth Design's portfolio in Q3 2026, its #373 holding.
  • True Wealth Design first reported a position in United Therapeutics in Q2 2023 and has held it in 14 quarters since.
  • True Wealth Design's United Therapeutics position peaked at $1.1M in Q2 2024.
  • 150 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.